Aryballe Technologies Appoints Top Consumer Industry Executive Jean-Christophe Simon as New Chairman of the Board to Help Drive Next Phase of Growth
Aryballe Technologies (www.aryballe-technologies.com), the pioneer in digital olfaction, has appointed Dr Jean-Christophe Simon as its Chairman of the Board. He will bring to Aryballe his vision about transformation of food tech and cosmetic industries. Aryballe’s bio-inspired “digital nose” NeOseTM Pro, mimicking the human olfactory receptors that recognize smells, uses sensors to detect, measure and identify several hundreds of odors improving quality control, safety, and sensory evaluation important to multiple industries. Dr Simon will drive Aryballe’s industry expansion as the demand and use applications for this smart sensory technology continues to increase.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180928005201/en/
Aryballe Technologies appoints Jean-Christophe Simon as new Chairman of the Board (Photo: Jean-Christophe Simon)
With more than 25 years in R&D and innovation management, Dr Simon joins Aryballe with a dynamic and proven successful career in the innovation of consumer products for the food, home appliances and cosmetic industries.
“We’re delighted and honored to welcome Jean-Christophe as Aryballe’s Chairman of the Board,” said Sam Guilaumé, Aryballe CEO. “His global industry experience and international vision will have a profound impact on our advancement as a global technology leader in digital olfaction and help position the company for transformative growth.”
“Aryballe’s technology is groundbreaking. I am excited to have the opportunity to build on Aryballe’s success in the food and beverage, fragrance and cosmetic, and automotive industries, and to help expand the reach of Aryballe’s versatile technology,” said Jean-Christophe Simon. “Aryballe has created diverse applications to deliver outstanding industry outcomes, B2B as well as B2C. I look forward to working with this experienced and passionate team to contribute to Aryballe’s next developments as Chairman of the Board.”
Most recently, Dr Simon, since his appointment in 2010, served as the Chief Innovation Officer and Senior Vice-President of the Group Research at Groupe SEB. Dr Simon started his career in public research. He then joined the cosmetic company L’Oréal before moving to Japan and Germany to bring his experience to the Kao group. He has held the position of president and representative director of the Nikon and Essilor International Joint Research Center.
“Jean-Christophe is uniquely suited to serve as Chairman and will play a vital role in capitalizing Aryballe’s recent accomplishments. He has the proven track record and leadership experience to make great strides as we innovate for the future of digital olfaction bringing smell to the forefront of smart technology,” added Tristan Rousselle, Aryballe’s Deputy CEO.
About Aryballe
Aryballe, a startup based in Grenoble, France, develops and manufactures bio-inspired odor sensors enabling groundbreaking applications in the food, cosmetics and automotive industries. Founded in 2014, it released its first product, the digital nose NeOseTM Pro in early 2018. Fast, portable and sensitive to hundreds of odors, NeOseTM Pro is used for quality control in the cosmetic industry, new flavors development in the Food & Beverage industry, or materials quality monitoring in the automotive industry.
For further information visit: www.aryballe-technologies.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180928005201/en/
Contact information
Media Contact:
Aryballe Technologies
Sam Guilaumé
sam@aryballe.com
contact@aryballe.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex Presents New Data on Benefits of ALYFTREK ® and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference6.6.2025 19:00:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data across multiple studies demonstrating positive clinical and quality of life benefits of treatment with CFTR modulators and, in particular, ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), which is approved in the United States and United Kingdom and is currently under review with health authorities in the EU, Canada, Australia, New Zealand and Switzerland. These data were presented at this year’s European Cystic Fibrosis Society’s (ECFS) 48th European Cystic Fibrosis Conference held June 4-7, 2025, in Milan, Italy. During the conference, the Company presented data from a pooled analysis across CFTR modulators, including ALYFTREK, which demonstrate that reduction in sweat chloride (SwCl), and therefore greater restoration of CFTR function, is associated with improved outcomes in people with cystic fibrosis (CF). For all clinical outcomes in the study, SwCl levels below 60 mmol/L were associated with greater benefit
IBSA Derma at IMCAS Asia 2025: spotlight on the future of aesthetic medicine in the 10 th Anniversary Year of NAHYCO ® Technology6.6.2025 17:00:00 EEST | Press release
IBSA Derma – the dermoaesthetic division of IBSA – once again confirms its leadership in the international aesthetic medicine landscape by participating in the 18th edition of IMCAS Asia, taking place from June 6 to 8 in Bangkok, Thailand. With over 3,000 attendees expected, the event represents a key opportunity for physicians and experts to share the latest innovations and cutting-edge advancements in aesthetic procedures and treatments, staying at the forefront of this dynamic field. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250603094257/en/ IBSA’s stand at IMCAS Asia 2025 As part of the congress, IBSA Derma will host a scientific symposium titled “The Future of Tissue Regeneration with NAHYCO® Technology. Feeling and Seeing the Results with Profhilo® Line” scheduled for Saturday, June 7, from 3:00 to 4:00 pm ICT in Room 1 - Level 2. Internationally renowned speakers – Dr. Lam Bee Lan and Prof. Ofir Artzi – will lead
HistoSonics Completes Enrollment in #HOPE4KIDNEY Trial Evaluating Non-Invasive Histotripsy to Treat Kidney Tumors6.6.2025 15:00:00 EEST | Press release
HistoSonics, Inc., the manufacturer of the Edison® Histotripsy System and novel histotripsy therapy platforms, today announced the completion of patient enrollment in its pivotal #HOPE4KIDNEY trial. This prospective, multi-center, single-arm trial is designed to evaluate the safety and effectiveness of the Edison System in destroying kidney tissue by treating primary solid kidney tumors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606659747/en/ Edison Histotripsy System Procedure for Kidney Tumor Animation The trial enrolled patients with a single, non-metastatic solid kidney mass ≤3 cm, confirmed by imaging and biopsy. Subjects will be followed for five years post-procedure, with evaluations at multiple time points, including 14-day, 30-day, 90-day, 180-day, and annual assessments. The Edison System remains in investigational use for kidney applications and is not yet FDA-approved for this indication. Data from the #H
Norwegian Tech Firm Builds Military Command Center in 24 Hours6.6.2025 14:45:00 EEST | Press release
The solution was showcased during a military exercise led by the Dutch Ministry of Defence and has already sparked interest from NATO members and civil protection agencies across Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606640770/en/ Cyviz demonstrates rapid deployment capability with a mobile, container-based control room for defense and crisis response Cyviz and its partners constructed the command room inside a 14-ton container designed for transport on standard military vehicles and resistant to machine gun fire. The unit was deployed at a military base in the Netherlands, where Cyviz was tasked with delivering a fully functional command-and-control environment, under strict time constraints and in a high-stakes simulation. "You don’t have time to build control rooms from scratch during an emergency. That’s why we designed something that’s mobile, fast to deploy, and fully secure”, says John van Laerhove
Multiply Group Lights up the World With the Launch of Multiply Media Group, Creating a Media Powerhouse Headquartered in the UAE6.6.2025 13:52:00 EEST | Press release
Multiply Group (ADX: MULTIPLY), the Abu Dhabi-based investment holding company, today launches Multiply Media Group (MMG), uniting the three market-leading out-of-home (OOH) companies under its portfolio to create a new media powerhouse headquartered in the UAE. The combination of BackLite Media, Viola Media and Media 247 under Multiply Media Group represents a significant move that will shape the future of tech-enabled media in the UAE and beyond. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606708480/en/ Multiply Group lights up the world with the launch of Multiply Media Group, creating a media powerhouse headquartered in the UAE (Photo: AETOSWire) Samia Bouazza, GCEO and Managing Director of Multiply Group, said: “The launch of Multiply Media Group represents the most significant media consolidations in the UAE. By bringing together market-leading media assets under a single AI & tech-driven group, we are reinforcin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom